In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis
- PMID: 6561954
- PMCID: PMC185490
- DOI: 10.1128/AAC.25.2.279
In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis
Abstract
Amikacin, combined with aztreonam, piperacillin, or ticarcillin, synergistically inhibited amikacin-resistant sputum isolates of Pseudomonas aeruginosa and P. cepacia from children with cystic fibrosis. Ticarcillin-amikacin was the least active combination. Aminoglycoside resistance should not preclude the use of beta-lactam-aminoglycoside combinations in the treatment of pulmonary infections in cystic fibrosis.
Similar articles
-
Comparison of cefpiramide (HR-810) and four anti-pseudomonal beta-lactam agents against pseudomonas isolates from children with cystic fibrosis.J Antimicrob Chemother. 1985 May;15(5):545-9. doi: 10.1093/jac/15.5.545. J Antimicrob Chemother. 1985. PMID: 3924879 Clinical Trial.
-
In vitro activity of aztreonam in combination with newer beta-lactams and amikacin against multiply resistant gram-negative bacilli.Antimicrob Agents Chemother. 1984 Feb;25(2):283-5. doi: 10.1128/AAC.25.2.283. Antimicrob Agents Chemother. 1984. PMID: 6538773 Free PMC article.
-
In vitro activities of antibiotic combinations against clincal isolates of Pseudomonas aeruginosa.Kaohsiung J Med Sci. 2004 Jun;20(6):261-7. doi: 10.1016/s1607-551x(09)70116-0. Kaohsiung J Med Sci. 2004. PMID: 15253466 Free PMC article.
-
Optimization of anti-pseudomonal antibiotics for cystic fibrosis pulmonary exacerbations: II. cephalosporins and penicillins.Pediatr Pulmonol. 2013 Feb;48(2):107-22. doi: 10.1002/ppul.22669. Epub 2012 Sep 4. Pediatr Pulmonol. 2013. PMID: 22949297 Review.
-
Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa.Pharmacotherapy. 2000 Sep;20(9 Pt 2):213S-218S; discussion 224S-228S. doi: 10.1592/phco.20.14.213s.35045. Pharmacotherapy. 2000. PMID: 11001328 Review.
Cited by
-
In vitro activity of aztreonam combined with tobramycin and gentamicin against clinical isolates of Pseudomonas aeruginosa and Pseudomonas cepacia from patients with cystic fibrosis.Antimicrob Agents Chemother. 1987 Sep;31(9):1403-5. doi: 10.1128/AAC.31.9.1403. Antimicrob Agents Chemother. 1987. PMID: 3118798 Free PMC article.
-
The epidemiology of Pseudomonas cepacia in patients with cystic fibrosis.Eur J Epidemiol. 1987 Dec;3(4):336-42. doi: 10.1007/BF00145642. Eur J Epidemiol. 1987. PMID: 3319668 Review.
-
In vitro activity of amiloride combined with tobramycin against Pseudomonas isolates from patients with cystic fibrosis.Antimicrob Agents Chemother. 1988 Mar;32(3):395-6. doi: 10.1128/AAC.32.3.395. Antimicrob Agents Chemother. 1988. PMID: 3364958 Free PMC article.
-
Use of the E test to assess synergy of antibiotic combinations against isolates of Burkholderia cepacia-complex from patients with cystic fibrosis.Eur J Clin Microbiol Infect Dis. 2003 Jan;22(1):28-34. doi: 10.1007/s10096-002-0852-8. Epub 2003 Jan 25. Eur J Clin Microbiol Infect Dis. 2003. PMID: 12582741
-
Comparative in vitro activities of meropenem, imipenem, temocillin, piperacillin, and ceftazidime in combination with tobramycin, rifampin, or ciprofloxacin against Burkholderia cepacia isolates from patients with cystic fibrosis.Antimicrob Agents Chemother. 1999 Feb;43(2):213-7. doi: 10.1128/AAC.43.2.213. Antimicrob Agents Chemother. 1999. PMID: 9925508 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical